![Susan Romanus](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Susan Romanus
Keine laufenden Positionen mehr
Vermögen: 196 971 $ am 31.05.2024
Karriereverlauf von Susan Romanus
Ehemalige bekannte Positionen von Susan Romanus
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Taiho Oncology, Inc.
![]() Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Compliance Officer | 01.01.2015 | 01.01.2018 |
DAIICHI SANKYO CO., LTD. | Compliance Officer | 01.01.2009 | 01.01.2012 |
Merck Vaccine Division | Compliance Officer | - | - |
ADC THERAPEUTICS SA | Compliance Officer | 01.08.2018 | - |
Ausbildung von Susan Romanus
University of California San Diego | Undergraduate Degree |
University of San Diego | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 5 |
Schweiz | 2 |
Japan | 2 |
Operativ
Compliance Officer | 4 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ADC THERAPEUTICS SA | Health Technology |
DAIICHI SANKYO CO., LTD. | Health Technology |
Private Unternehmen | 2 |
---|---|
Taiho Oncology, Inc.
![]() Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Health Technology |
Merck Vaccine Division |
- Börse
- Insiders
- Susan Romanus
- Erfahrung